— Know what they know.
Not Investment Advice

EDAP NASDAQ

Edap Tms S.a.
1W: +11.2% 1M: +44.0% 3M: +16.6% YTD: +40.6% 1Y: +167.0% 3Y: -52.3% 5Y: -29.6%
$4.75
Last traded 2026-06-01 — delisted
NASDAQ · Healthcare · Medical - Specialties · $178.2M mcap · 37M float · 0.105% daily turnover · Short 33% of daily vol

Balance Sheet Trends

Total Assets
$67M -21.9% ▼
5Y CAGR: +4.0%
Total Liabilities
$51M +12.3% ▲
5Y CAGR: +11.9%
Shareholders Equity
$17M -59.6% ▼
5Y CAGR: -8.8%
Cash & Investments
$17M -41.7% ▼
5Y CAGR: -6.8%
Total Debt
$2M -85.2% ▼
5Y CAGR: -28.6%
Net Debt
-$15M +3.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$47M$63M$43M$30M$17M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$47M$63M$43M$30M$17M
Net Receivables$12M$15M$17M$20M$19M
Inventory$7M$12M$15M$18M$11M
Other Current Assets-$1K$0$2M-$3K$421
Total Current Assets$67M$91M$78M$70M$49M
Property, Plant & Equip.$5M$6M$8M$10M$11M
Goodwill & Intangibles$3M$3M$3M$3M$2M
Long-Term Investments$0$0$0$0$465K
Other Non-Current Assets$634K$656K$1M$2M$4M
Total Non-Current Assets$10M$11M$13M$16M$19M
Total Assets$77M$101M$92M$86M$67M
— Liabilities —
Accounts Payable$6M$7M$11M$13M$18M
Short-Term Debt$3M$3M$4M$9M$8M
Deferred Revenue$3M$4M$84K$7M$6M
Other Current Liabilities$2M$2M$5M$3M$7K
Total Current Liabilities$18M$22M$28M$38M$32M
Long-Term Debt$5M$4M$2M$2M$14M
Other Non-Current Liab.$3M$3M$3M$3M$3M
Total Non-Current Liabilities$9M$8M$7M$7M$19M
Total Liabilities$27M$29M$35M$45M$51M
— Equity —
Common Stock$4M$5M$5M$5M$5M
Retained Earnings-$39M-$42M-$64M-$83M-$109M
Accumulated OCI-$4M-$4M-$4M-$5M-$7M
Total Stockholders Equity$50M$72M$57M$41M$17M
Total Liabilities & Equity$77M$101M$92M$86M$67M
— Key Metrics —
Total Debt$10M$9M$8M$14M$2M
Net Debt-$37M-$54M-$35M-$16M-$15M
Total Investments$0$0$0$0$465K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms